Since extracellular ketone bodies have been found to inhibit tumor growth through various mechanisms, including HDAC inhibition20,33, we next determined whether hepatic PAK4 deficiency-enhanced ketogenesis suppresses tumor growth in in vivo tumor transplantation models; subcutaneous and orthotopic tumor models. This evidence concerns the gene HDAC9 and neoplasm.